K. Stephen Suh, PhD

Lab Director, Tumor Banks and Genomics Program, Hackensack University Medical Center

Dr. K. Stephen Suh is currently a scientific/laboratory director for the Tumor Bank and Genomics Program at the John Theurer Cancer Center of Hackensack University Medical Center in New Jersey. His interest is biomarker discovery program and development of molecular diagnostic and prognostic assays for multiple human cancer types. He uses bioinformatics, genomics and proteomics approaches to discover biomarkers for early detection, to predict clinical outcome and to enhance personalized cancer care.  Current research projects include lymphoma to model liquid tumors and ovarian, breast and prostate cancers to represent solid tumors. 

His graduate training at the University of Texas was focused on basic science by studying molecular pathways and cellular signaling of Src family of tyrosine kinases. He finished his postdoctoral training and research/staff fellowship at the National Cancer Institute (NCI) from 1998 to 2007. At NCI, he led a team of scientists to discover Chloride Intracellular Channel 4 (CLIC4) as a biomarker for tumor progression and became a world expert in molecular circuitry of CLIC pathways. At the NCI, he focused on translational science by working with carcinogenesis and xenograft mouse models.  He is currently developing expertise in biomarker-based bench-to-bed side research and clinical science at the medical center.  Dr. Suh presents his works at national and international scientific conferences and has received numerous recognitions and awards from the National Institute of Health/National Cancer Institute (NIH/NCI), American Association of Cancer Research (AACR), MD Anderson Cancer Center, Aspen Cancer Conference and Society for Investigative Dermatology.